Nanjing Ruiying Runze Biopharmaceutical Technology Co.; Inc.
发明人:
Jing Shang,Lin Ding,Guohong Qin,Tao Wang,Jun Liu,Yu Li,Ting He
申请号：
US15308852
公开号：
US20170100421A1
申请日:
2015.03.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed are a compound pharmaceutical composition containing Cichorium glandulosum Boiss et Hout as a lipid-lowering active ingredient and the use of the composition for preparing a drug for treating or preventing lipid metabolism disorders, wherein the composition comprises a pharmaceutically active ingredient and a pharmaceutically acceptable carrier, wherein the pharmaceutically active ingredient consists of quercetin-3-O-β-D-glucuronoside, isoquercitrin and quercetin at a molar ratio of 1.1-2.4:1.3-3.3:1.2-3.1.
